NeoGenomics, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
NeoGenomics, Inc. (NEO) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $6.65 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-07-28
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $6.65M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $54.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $6.65M 10-Q · filed 2026-07-28 |
| 2025-12-31 | $54.00K 10-Q · filed 2026-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |